Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Total Voting Rights

1 May 2024 12:00

RNS Number : 8472M
Kainos Group plc
01 May 2024
Β 

01 May 2024

Kainos Group plc

("Kainos" or the "Company")Β 

Total Voting Rights

Β 

Pursuant to DTR 5.6.1 the Company announces that as at 01 May 2024, the total number of ordinary shares in issue now stands at 125,820,677 each with voting rights. There are no shares held in treasury.

Β 

The above figure 125,820,677 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Β 

Classification: 2.5 - Total number of voting rights and capital

Β 

Β 

Ends

Β 

For further information, please contact:

Β 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

Β 

Investec Bank plc +44Β 20 7597 5970

Patrick Robb / Ben Griffiths

Β 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

Β 

About Kainos

Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions -Β Digital Services, Workday Services, and Workday Products.

Β 

Our Digital Services division develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users.Β 

Β 

Our Workday Services division specialises in the deployment of Workday Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems.

Β 

Our Workday Products division develops products that complement Workday. Our Smart product suite, includingΒ Smart TestΒ (for automated testing),Β Smart AuditΒ (for compliance monitoring), andΒ Smart ShieldΒ (for data masking), are used by more than 400 customers globally to safeguard their Workday systems.

Β 

Our people are central to our success. We employ more than 3,100 people in 23 countries across Europe, Asia and the Americas.Β 

Β 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us atΒ www.kainos.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRBFLFBZELEBBK
Date   Source Headline
1st Aug 20233:58 pmRNSTotal Voting Rights
21st Jul 20235:11 pmRNSAnnual Report 2023
3rd Jul 20231:20 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSAcquisition of RapidIT-Cloudbera, Inc.
23rd Jun 202312:55 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSPlanned CEO Transition
1st Jun 202311:23 amRNSTotal Voting Rights
23rd May 20234:36 pmRNSHolding(s) in Company
22nd May 20237:00 amRNSFinal Results
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 20237:00 amRNSAppointment of Independent Non-Executive Director
19th Apr 20237:00 amRNSTrading Statement
3rd Apr 20232:30 pmRNSTotal Voting Rights
17th Mar 20235:05 pmRNSHolding(s) in Company
1st Mar 202312:07 pmRNSTotal Voting Rights
1st Feb 20239:35 amRNSTotal Voting Rights
30th Dec 20229:53 amRNSTotal Voting Rights
29th Dec 202210:20 amRNSHolding(s) in Company
21st Dec 20224:58 pmRNSHolding(s) in Company
20th Dec 20224:15 pmRNSDirector/PDMR Shareholding
7th Dec 20228:40 amRNSHolding(s) in Company
1st Dec 202212:10 pmRNSTotal Voting Rights
18th Nov 20224:38 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSHalf-year Report
18th Oct 20227:00 amRNSUpdate on office development & partial site sale
3rd Oct 202211:14 amRNSTotal Voting Rights
28th Sep 20222:04 pmRNSResult of AGM
1st Sep 20222:05 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSTrading Statement
24th Aug 20222:07 pmRNSNotice of AGM
1st Aug 202211:12 amRNSTotal Voting Rights
29th Jul 202210:12 amRNSPublication of Annual Report 2022
29th Jul 20227:00 amRNSWorkday Partner Status Update
1st Jul 20225:36 pmRNSDirector Share Awards
29th Jun 202210:15 amRNSDirector/PDMR Shareholding
20th Jun 20225:22 pmRNSHolding(s) in Company
1st Jun 202211:42 amRNSTotal Voting Rights
23rd May 20227:00 amRNSFull Year Results
4th May 202210:56 amRNSTotal Voting Rights
19th Apr 20227:00 amRNSTrading Statement
31st Mar 20222:33 pmRNSTotal Voting Rights
1st Mar 20221:21 pmRNSTotal Voting Rights
21st Feb 20227:00 amRNSPlanalyse acquisition strengthens Kainos
1st Feb 202212:40 pmRNSTotal Voting Rights
11th Jan 20227:00 amRNSKainos acquires Blackline Group
10th Jan 20224:14 pmRNSDirector/PDMR Shareholding
31st Dec 202110:26 amRNSTotal Voting Rights
13th Dec 20213:26 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:23 pmRNSTotal Voting Rights
24th Nov 20211:11 pmRNSPerson Closely Associated shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.